Back
Arcutis Biotherapeutics Vs. Natera Industry Stock Comparison
Sell
35
ARQT
Arcutis Biotherapeutics
Last Price:
9.93
Seasonality Move:
47.83%
Buy
81
NTRA
Natera
Last Price:
150.95
Seasonality Move:
3.03%
Sell
35
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.47. The Score for ARQT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Natera (NTRA)
is a Buy
Is Natera a Buy, Sell or Hold?
- The current Natera [NTRA] share price is $160.90. The Score for NTRA is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- NTRA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.47
The current trend is moderately bullish and ARQT is experiencing slight buying pressure.
NTRA Stock Price Chart
ARQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 62.36 | Buy |
| Chaikin Money Flow: | 442619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.47 - 10.13) | Buy |
| Bollinger Bands (100): | (8.95 - 10.45) | Buy |
NTRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 81.36 | Buy |
| Chaikin Money Flow: | 575579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.54 - 135.54) | Buy |
| Bollinger Bands (100): | (108.16 - 128.76) | Buy |
ARQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.09 | Buy |
| 20-day SMA: | 9.2 | Buy |
| 50-day SMA: | 9.69 | Buy |
| 200-day SMA: | 9.36 | Buy |
| 8-day EMA: | 10.1 | Buy |
| 20-day EMA: | 9.64 | Buy |
| 50-day EMA: | 9.56 | Buy |
| 200-day EMA: | 9.11 | Buy |
NTRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.67 | Buy |
| 20-day SMA: | 126.59 | Buy |
| 50-day SMA: | 125.86 | Buy |
| 200-day SMA: | 105.32 | Buy |
| 8-day EMA: | 137.09 | Buy |
| 20-day EMA: | 130.38 | Buy |
| 50-day EMA: | 125.47 | Buy |
| 200-day EMA: | 105.77 | Buy |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Natera Earnings Growth & NTRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.24 per share, and an increase next year of $0.23 per share.
Arcutis Biotherapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Natera Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||